https://www.selleckchem.com/pr....oducts/GSK872-GSK239
3% [24/45] vs. 55.3% [26/47]; P = 1.00 but significantly higher than that in group 3 (53.3% [24/45] vs. 28.2% [42/149], P = 0.002). Seven-year OS rates in group 2 were similar to those in group 1 (55.6% vs. 60.8%, P = 0.988) but significantly lower than those in group 3 (55.6% vs. 83.3%, P = 0.001). Presence of standard CSPH surrogate (hazard ratio = 1.89 [1.08-3.30], P = 0.025) and CT-enhanced CSPH surrogate (hazard ratio = 2.60 [1.56-4.39], P less then 0.001) were significant predicting factor for OS. However, CT-enhanced
Like
Comment
Share
